Drug Profile
Research programme: antimalarials - Pharmacopeia/World Health Organization
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Pharmacopeia; Tropical Disease Research Program of the World Health Organization
- Developer Pharmacopeia; Special Programme for Research and Training in Tropical Diseases
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Malaria in Switzerland
- 04 Nov 2017 No recent reports of development identified for research development in Malaria in USA
- 12 Oct 2009 Research is ongoing in USA and Switzerland